Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

78 results about "Oxidative cyclization" patented technology

Thiophene macrocyclic compound and preparation method for its derivant

InactiveCN101343280AHigh production yieldPracticalOrganic chemistryOxidative cyclizationOxygen
The invention relates to a thiophene macrocyclic compound and a preparation method of derivatives of the thiophene macrocyclic compound, in particular to a preparation method of a thiophene eight membered cyclic compound and a thiophene twelve membered cyclic compound. The preparation method is as follows: 2, 2`-dibromo-[3, 3`]-bithiophene is adopted as the raw material; lithium diisopropylamide (LDA) is firstly used to capture the Alpha- proton, then the 2, 2`-dibromo-[3, 3`]-bithiophene is quenched by trimethylchlorosilane, and a compound 3 is prepared; then the compound 3 and butyl lithium generate bromine and lithium exchanging reaction, and copper chloride oxidative cyclization is used to generate thiophene eight membered cyclic compound 4 and thiophene twelve membered cyclic compound 5, wherein, the yield of the compound 5 reaches up to 36 percent; and in the condition that trifluoroacetic exists, the compound 4 and the compound 5 remove TMS, and a compound 1-four (2,3-bithiophene) and a compound 2-six (2,3-bithiophene) are obtained. The preparation method of the derivatives of the thiophene macrocyclic compound realizes the aim of preparing the thiophene eight-membered cyclic compound at high yield, and most importantly, the preparation method realizes the aim of preparing the thiophene twelve-membered cyclic compound at high yield, and the total yield of the three steps reaches up to 27 percent. The synthetic process of the method has operability, and the reaction conditions of waterless, oxygen free and low-temperatured. Thus, the preparation method is suitable for scale preparation.
Owner:HENAN UNIVERSITY

Application of porphyrin-based covalent organic framework material in photocatalytic oxidation cyclization reaction

The invention relates to the technical field of catalytic synthesis, and concretely relates to application of a porphyrin-based covalent organic framework material in photocatalytic oxidation cyclization reaction. The structure of the porphyrin-based covalent organic framework material is as shown in formula I. A synthesis method of an N-methyltetrahydro-1H-pyrrolo[3, 4-c]-quinoline-1, 3(2H)-dione derivative comprises the following steps: adding an N, N-dimethylaniline derivative and a maleimide derivative into an organic solvent to obtain a solution A; adding the material in the formula I into the solution A to obtain a solution B; and irradiating the solution B with visible light to obtain a product. A metal-free covalent organic framework based on a porphyrin structure is used as a photosensitizer, oxygen is used as an oxidizing agent, an oxidative cyclization reaction of the N, N-dimethylaniline derivative and the maleimide derivative is realized under the irradiation of visible light, and the tetrahydroquinoline compound is efficiently constructed; and the method is green and mild in condition, the photosensitizer can be recycled, the utilization rate of the photosensitizer is increased, the cost is reduced, and industrial popularization and application are facilitated.
Owner:SHANDONG NORMAL UNIV

Preparation method of intermediate of antibacterial drug

The invention provides a preparation method of phosphamycin levophosphorylamine. The preparation method comprises the following steps: dissolving cis-propenylphosphonic acid in an alcohol solvent at room temperature, slowly dropwise adding (+)-alpha-phenylethylamine, regulating the pH value of the formed system to 5.5-6, continuing stirring for 1-3 minutes, adding a silver catalyst, slowly and dropwise adding hydrogen peroxide, continuing stirring for 10-30 minutes, then rapidly heating the system to 50-55 DEG C, conducting filtering while the system is hot, and then cooling, crystallizing andwashing the filtrate successively to obtain the phosphamycin levophosphorylamine. According to the invention, silver carbonate is used as a catalyst, hydrogen peroxide is used as an oxidizing agent,heating is not needed in an oxidative cyclization process, and a reaction can be performed at normal temperature. The silver carbonate has very high catalytic activity in the invention, and compared with the prior art, the method has the advantages of small dosage, mild reactions, effective shortening of reaction time, simple post-treatment, and realization of separation of the catalyst from the system only through filtration of the system while the system is hot.
Owner:SINOPHARM ZHIJUN (SHENZHEN) PHARMA CO LTD

Application of silver catalyst in preparation of antibacterial drug intermediate

The invention provides an application of a silver catalyst in preparation of an antibacterial drug intermediate fosfomycin levoforight amine salt. The application is characterized by comprising the following steps: at room temperature, dissolving cis-propenylphosphonic acid in an alcohol solvent, slowly dropwise adding (+) alpha phenylethylamine, regulating the pH value of the system to 5.5-6 after dropwise adding, continuing stirring for 1-3 minutes, and adding the silver catalyst, continuously and slowly dropwise adding hydrogen peroxide, then continuously stirring for 10-30 minutes, quicklyheating the system to 50-55 DEG C, filtering while the system is hot, and cooling, crystallizing and washing the filtrate to obtain the fosfomycin levoforight amine salt. Silver carbonate is used asthe catalyst, hydrogen peroxide is used as an oxidizing agent, heating is not needed in the oxidative cyclization process, and the reaction can be performed at normal temperature. Silver carbonate hasvery high catalytic activity in the invention, and compared with the prior art, the application has the advantages of small dosage, mild reaction, effective shortening of the reaction time, simple post-treatment, and realization of separation of the catalyst from the system only through filtration of the system while the system is hot.
Owner:商河探荣新技术开发中心
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products